Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): ЕА11924
Who filed: ОФ "Answer"
Country: Kazakhstan
Opposition type: Post-Grant
Opposition status: Refused
Date: 19-03-2020
Patent type: Polymorphs

Click within the document, or manually enter the page number below

People Plus Non-Governmental Organization opposition, Lopinavir/Ritonavir, (PCT/US2004/027401 (EA11924))

Countries: Belarus Date: 2020
People PLUS opposition, Lopinavir/Ritonavir, (EAPO № 011924)

Countries: Belarus Date: 2020
Indian Network of People Living with HIV/AIDS (INP+), Delhi Network of Positive People (DNP+) and Network of Maharashtra People with HIV (NMP+) opposition, lopinavir (LPV) , (IN/PCT/2002/1243/MUM)

Countries: India Date: 2006
Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (894/MUMNP/2007 (Divisional of IN/PCT/2002/1243/MUM))

Countries: India Date: 2011
Matrix Laboratories Ltd. opposition, lopinavir (LPV) , (259/MUMNP/2003)

Countries: India Date: 2010
CILFA opposition, lopinavir (LPV) , (P060100645)

Countries: Argentina Date: 2012
ABIA/GTPI opposition, Atazanavir, (PI0509595-6)

Countries: Brazil Date: 2020
Sankalp Rehabilitation Trust opposition, Rilpivirine, (2110/MUMNP/2013)

Countries: India Date: 2020
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)

Countries: India Date: 2007
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010

оф "Answer" Opposition, Lopinavir, (еа11924)